Cycle Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCycle Pharmaceuticals

Cycle Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Chlorpromazine	Chlorpromazine	1982-01-01		Acute intermittent porphyria , Anxiety disorders , Attention deficit and disruptive behavior disorders , Child behavior disorders , Hiccup , Nausea , Psychotic disorders , Schizophrenia , Tetanus , Vomiting
Cimetidine	Cimetidine	1994-12-23		Duodenal ulcer , Dyspepsia , Gastroesophageal reflux , Heartburn , Helicobacter infections , Peptic esophagitis , Stomach ulcer , Urticaria , Zollinger-ellison syndrome
Indomethacin	Indomethacin	1985-06-18	2030	Ankylosing spondylitis , Bursitis , Gouty arthritis , Inflammation , Osteoarthritis , Pain , Patent ductus arteriosus , Rheumatoid arthritis , Tendinopathy
Nityr	Nitisinone	2018-07-26	2033-2035	Tyrosinemias
Piroxicam	Piroxicam	1993-02-26		Ankylosing spondylitis, Inflammation, Osteoarthritis, Rheumatoid arthritis, Sunburn
Quinidine	Quinidine	1982-01-01	2023-2026	Neurobehavioral manifestations, Atrial fibrillation, Atrial flutter, Cardiac arrhythmias
Reserpine	Reserpine	1982-01-01		Dyskinesias, Hypertension, Schizophrenia
Tascenso	Fingolimod lauryl	2021-12-23	2026-2032	Multiple sclerosis, Relapsing-remitting multiple sclerosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

psychomotor agitation

,

acute intermittent porphyria

,

oral manifestations

,

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use